NovoLog Label Change

NovoLog users may find comfort in the FDA’s recent label change of this rapid-acting insulin. NovoLog’s label now recommends that it can now be kept in pump reservoirs for up to six days, an increase over the previously recommended two days. The new label also increased the recommended time NovoLog patients should change their pump infusion sets from a minimum of every 48 hours to every three days. NovoLog is now the only rapid-acting insulin with an extended in-use pump time. Although these are only recommendations, and while we frankly believe the majority of pump users may not have followed the previous label religiously, this news should give patients the peace of mind that they can keep insulin in their pump reservoirs longer and change their infusion sets less frequently without sacrificing the quality of their glycemic control.